SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a leading molecular diagnostics company, today
announced the Company's participation at the 2015 J.P. Morgan
Healthcare Conference at the Westin St. Francis Hotel, in
San Francisco, CA on January 12-15, 2015.
William Welch, Chief Executive
Officer, and Carolyn Beaver, Chief
Financial Officer, will present on Thursday,
January 15 at 8:00 a.m. PT to
provide an overview of and update on the Company. The presentation
is expected to last approximately 30 minutes and will be webcast
live through the "Invest" section of the Sequenom Web site at
www.sequenom.com. An audio replay will be available for 30 days
following the initial broadcast.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier
lives through the development of innovative products and
services. The company serves patients and physicians by
providing early patient management information. To learn how
Sequenom is interpreting the genome to improve your life, visit
www.sequenom.com and follow @SequenomLabs.
Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-inc-announces-participation-at-the-33rd-annual-jp-morgan-healthcare-conference-300016081.html
SOURCE Sequenom, Inc.